Aravive Inc (FRA:VE11)
€ 0.0325 0 (0%) Market Cap: 2.72 Mil Enterprise Value: -2.92 Mil PE Ratio: 0 PB Ratio: 1.74 GF Score: 0/100

Aravive Inc GAS6-AXL Key Opinion Leader (KOL) Symposium & Development Strategy For AVB-S6-500 Corporate Call Transcript

Feb 05, 2019 / 01:00PM GMT
Release Date Price: €3.56 (-2.73%)
Unidentified Company Representative Aravive
Inc.

All right. Well, thank you, everybody, for joining us this morning for Ararive GAS6/AXL Key Opinion Leader Symposium. Just to let everyone know in the room, this event will be webcast. When we get to the Q&A section, we'll be passing around the mike. So please wait for the mike so the folks from the webcast can hear the question.

So before turning it over to Jay, Gail, and our distinguished KOLs, I am going to read through a brief forward-looking statement; and you can also find it here on the slide. I'd like to remind you that during this event, Aravive will make certain statements that are considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including our business plans and objectives, and timing and success of our clinical trials. Such forward-looking statements are not guarantees of future performance, and therefore you should not put undue reliance upon them. These statements are subject to numerous risks and uncertainties that could cause actual results to differ materially

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot